Brad Pitt’s F1 film may not be entirely based on a true story but the plotlines are familiar to the real-life world of grand prix racing: a horrific high-speed crash; a returning champion; struggling ...

Sundance Film Festival debut of Magazine Dreams drew critical accolades for Jonathan Majors’ portrayal of a troubled (to put ...

The Los Angeles Sparks will enter the new season in May with renewed optimism with the arrival of Kelsey Plum and the return of Cameron Brink. Plum was acquired by the Sparks in a three-team trade ...

Los Angeles Sparks star Cameron Brink got candid about her fiancée’s thoughts on her daring outfit. When she's not rocking her basketball jersey, the WNBA star experiments with fashion trends ...

Los Angeles Sparks forward Cameron Brink looks on before the women’s college basketball game between the Notre Dame Fighting Irish and the USC Trojans. / IMAGO / Icon Sportswire Cameron Brink is ...

LA Sparks forward Cameron Brink leaves the floor after the game against the Las Vegas Aces at Crypto.com Arena. / Kirby Lee-Imagn Images Los Angeles Sparks forward Cameron Brink makes most people ...

Russian President Vladimir Putin's regime suggested relations between Washington, D.C., and Moscow are on "the brink" of collapse this week. Russian Deputy Foreign Minister Sergei Ryabkov made the ...

Sydney Fish Market is mired in a financial crisis just as its $1billion taxpayer-funded new building nears completion. The company's delayed financial statements are yet to be published but it ...

Pakistan is hoping that hosting its first major multi-country cricket tournament in nearly 30 years will help erase worries of instability in the country and restore confidence in it as a tourism ...

But some of us never stop thinking about whitetails and are already working out when to plant deer food plots this off season for even better hunting in the fall. Spring is the season for hope ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra (fo ...